Edition:
United Kingdom

People: AMAG Pharmaceuticals Inc (AMAG.OQ)

AMAG.OQ on NASDAQ Stock Exchange Global Select Market

8.80USD
9:00pm BST
Change (% chg)

$0.06 (+0.69%)
Prev Close
$8.74
Open
$8.76
Day's High
$8.88
Day's Low
$8.70
Volume
198,661
Avg. Vol
268,997
52-wk High
$26.08
52-wk Low
$7.81

Lennox, Linda 

Ms. Linda Lennox is Vice President of Investor Relations, & Corporate Communications of AMAG Pharmaceuticals, Inc. Ms. Lennox has 25 years of leadership experience with companies in the healthcare and energy sectors. Prior to joining AMAG, Ms. Lennox served as senior director, investor relations & corporate communications at Lantheus Medical Imaging, Inc., a privately held global diagnostic imaging company. Prior to that, Ms. Lennox served as vice president, investor & media relations at Critical Therapeutics, a publicly traded biotechnology/specialty pharmaceutical company. Prior to joining Critical Therapeutics, Ms. Lennox spent 15 years in positions of increasing responsibility at two separate publicly traded energy companies. Ms. Lennox started her career at Putnam Investments and Smith Barney, where she obtained her series 6, 7 and 63 licenses. She received a bachelor's degree in economics from the University of Vermont.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gino Santini

282,981

William Heiden

4,966,220

Edward Myles

1,537,340

Elizabeth Bolgiano

--

Joseph Vittiglio

1,203,710

J. Alan Butcher

2,083,060
As Of  31 Dec 2018